Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)
Clinical trial NCT02038946 · COMPLETED
Trial details
- NCT number
- NCT02038946
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-26
- Primary completion
- 2017-05-17
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.